Treatment costs will vary by country and patient. However, since Symbicort SMART is a more effective treatment approach than higher fixed-dose ICS/LABA regimens, Symbicort SMART has been shown to reduce costs compared to traditional combination therapy (Johansson et al 2006; Price et al 2006).
For several EU countries, Symbicort SMART has reduced total costs and direct costs compared to alternative regimens (Johansson et al 2006; Price et al 2006).
|
